Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability, Food Effect, and Interaction of GSK2140944
NCT02045849Phase 1Completed
- Sponsor
- GSK
- Start
- Jan 2014
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of gepotidacin in bacterial infection (3 arms), sponsored by GSK. Primary endpoints: Composite of PK parameters following GSK2140944 administration at Day 7, Safety and tolerability as assessed by adverse events at 8 weeks and 4 more. Started Jan 2014; status: completed.
02
Drugs
gepotidacin
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT02045849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02045849.